Clinical trials: GSD1
Glycogen Storage Disease Type IA
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia
Glycogen storage disease type Ia (GSDIa) subjects retain a limited capacity for endogenous glucose production (EGP). To date, the origin of residual EGP in GSDIa patients is unknown.
- Trial name
- ENGLUPRO GSDIa (NCT04311307)
- Testing
- [6,6-2H2]glucose
- Where
- Netherlands
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University Medical Center Groningen